George Elston | CFO & Head, Corporate Development |
Nancy Lurker | President, CEO & Director |
Jay Duker | Chief Strategic Scientific Officer |
Scott Jones | Chief Commercial Officer |
Georgi Yordanov | Cowen and Company |
Jennifer Kim | Cantor Fitzgerald & Co. |
Devin Geiman | Guggenheim Securities |
Yi Chen | H.C. Wainwright & Co. |
Andrew D'Silva | B. Riley Securities |
I-Eh Jen | Laidlaw & Company |
Welcome to the EyePoint First Quarter 2021 Financial Results Conference Call. [Operator Instructions]. I would now like to hand the conference over to your speaker today, George Elston, Chief Financial Officer. Please go ahead.
Thank you, and thank you all for joining us on today's conference call to discuss EyePoint Pharmaceuticals' First Quarter 2021 financial results and recent corporate developments.